Literature DB >> 437550

Liver damage associated with perhexiline maleate.

D Lewis, H C Wainwright, M C Kew, S Zwi, C Isaacson.   

Abstract

Two patients who developed biochemical and histological evidence of hepatitis while taking the anti-anginal drug perhexiline maleate are described. The pathological changes were those of mild to moderate fatty change together with a hepatitis which resembled alcoholic hepatitis, including in one patient the presence of material which by light microscopy was indistinguishable from Mallory's alcoholic hyalin. However, the predominantly periportal location of this material contrasted with the centrilobular distribution of Mallory's hyaline. One patient showed, in addition, severe atypia of the hepatocytes which was still present in less pronounced form 10 weeks after stopping perhexiline. The other patient had advanced hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437550      PMCID: PMC1412298          DOI: 10.1136/gut.20.3.186

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Long-term perhexiline maleate and liver function.

Authors: 
Journal:  Br Med J       Date:  1976-01-17

2.  Polyneuropathy after perhexiline maleate therapy.

Authors:  F Lhermitte; M Fardeau; F Chedru; J Mallecourt
Journal:  Br Med J       Date:  1976-05-22

3.  [Letter: Hepatitis medicamentosa caused by perhexiline].

Authors:  M Beaugrand
Journal:  Nouv Presse Med       Date:  1976 Jul 3-10

4.  Proceedings: Assessment of safety data from patients on short and long-term perhexiline therapy.

Authors:  J W Newberne
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

5.  Proceedings: Long-term assessment of perhexiline maleate in angina pectoris.

Authors:  J Pilcher; K P Chandrasekhar; J R Rees; M J Boyce; T H Peirce; H Ikram
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

6.  Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans.

Authors:  P P Anthony
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

7.  [Letter: Hypoglycemia and perhexilline].

Authors:  G Feldman
Journal:  Nouv Presse Med       Date:  1974 Nov 30-Dec 14

8.  Liver damage after perhexiline maleate.

Authors:  P Kopelman; P G Morgan
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  Liver damage after perhexiline maleate.

Authors:  G S McDonald
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

10.  Liver ganglioside storage after perhexiline maleate.

Authors:  A Lageron; R Poupon; P P de Saint-Maur; V G Lévy
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

View more
  12 in total

1.  Liver damage due to perhexiline maleate.

Authors:  G B Forbes; M O Rake; D J Taylor
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

2.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

Review 3.  Alcohol induced liver disease.

Authors:  K A Fleming; J O McGee
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

4.  "Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen.

Authors:  K Seki; Y Minami; M Nishikawa; S Kawata; S Miyoshi; Y Imai; S Tarui
Journal:  Gastroenterol Jpn       Date:  1983-06

5.  Perhexiline maleate toxicity on human liver cell lines.

Authors:  J Y Le Gall; A Guillouzo; D Glaise; Y Deugnier; M Messner; M Bourel
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

6.  Polymorphic hydroxylation of perhexiline maleate in man.

Authors:  R G Cooper; D A Evans; E J Whibley
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

7.  Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate.

Authors:  H Saner; H P Gurtner; R Preisig; A Küpfer
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Severe ocular side effects of perhexilene maleate: case report.

Authors:  J M Gibson; A R Fielder; A Garner; P Millac
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

9.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

10.  Impaired oxidation of debrisoquine in patients with perhexiline liver injury.

Authors:  M Y Morgan; R Reshef; R R Shah; N S Oates; R L Smith; S Sherlock
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.